Abstract
Carpetimycins A and B showed widely broad spectra and potent activity against gram-positive and gram-negative bacteria, including various species of anaerobic bacteria. The antimicrobial activity of carpetimycin A was 8 to 64 times greater than that of carpetimycin B and 4 to 128 times greater than that of cefoxitin. The inhibitory concentration of carpetimycin A required to inhibit more than 90% of clinical isolates was 0.39 micrograms/ml for Escherichia coli and klebsiella and 1.56 microgram/ml for Proteus and Staphylococcus aureus. At a concentration of 3.13 micrograms/ml, carpetimycin A inhibited almost all clinical isolates of Enterobacter and Citrobacter, which showed resistance to many clinically used beta-lactam antibiotics. Carpetimycins A and B furthermore were shown to have potent inhibitory activities against several kinds of beta-lactamases produced by beta-lactam-resistant strains; they inhibited not only penicillinase-type beta-lactamases but also cephalosporinase-type beta-lactamases, which were insensitive to clavulanic acid. In combination with beta-lactam antibiotics such as ampicillin, carbenicillin, and cefazolin, carpetimycins A and B showed synergistic activities against beta-lactam-resistant bacteria.
Full text
PDF








Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Basker M. J., Boon R. J., Hunter P. A. Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383. J Antibiot (Tokyo) 1980 Aug;33(8):878–884. doi: 10.7164/antibiotics.33.878. [DOI] [PubMed] [Google Scholar]
- Brown A. G., Corbett D. F., Eglington A. J., Howarth T. T. Structures of olivanic acid derivatives MM 22380, MM 22381, MM 22382 and MM 22383; four new antibiotics isolated from Streptomyces olivaceus. J Antibiot (Tokyo) 1979 Sep;32(9):961–963. doi: 10.7164/antibiotics.32.961. [DOI] [PubMed] [Google Scholar]
- DIXON M. The determination of enzyme inhibitor constants. Biochem J. 1953 Aug;55(1):170–171. doi: 10.1042/bj0550170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirai K., Iyobe S., Inoue M., Mitsuhashi S. Purification and properties of a new beta-lactamase from Pseudomonas cepacia. Antimicrob Agents Chemother. 1980 Mar;17(3):355–358. doi: 10.1128/aac.17.3.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hood J. D., Box S. J., Verrall M. S. Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. II. Isolation and characterisation of the olivanic acids MM 4550, MM 13902 and MM 17880 from Streptomyces olivaceus. J Antibiot (Tokyo) 1979 Apr;32(4):295–304. doi: 10.7164/antibiotics.32.295. [DOI] [PubMed] [Google Scholar]
- Nakayama M., Iwasaki A., Kimura S., Mizoguchi T., Tanabe S., Murakami A., Watanabe I., Okuchi M., Itoh H., Saino Y. Carpetimycins A and B, new beta-lactam antibiotics. J Antibiot (Tokyo) 1980 Nov;33(11):1388–1390. doi: 10.7164/antibiotics.33.1388. [DOI] [PubMed] [Google Scholar]
- Nakayama M., Kimura S., Tanabe S., Mizoguchi T., Watanabe I., Mori T., Miyahara K., Kawasaki T. Structures and absolute configurations of carpetimycins A and B. J Antibiot (Tokyo) 1981 Jul;34(7):818–823. doi: 10.7164/antibiotics.34.818. [DOI] [PubMed] [Google Scholar]
- Nozaki Y., Kawashima F., Imada A. C-19393 S2 and H2, new carbapenem antibiotics. III. Mode of action. J Antibiot (Tokyo) 1981 Feb;34(2):206–211. doi: 10.7164/antibiotics.34.206. [DOI] [PubMed] [Google Scholar]
- Okamura K., Sakamoto M., Fukagawa Y., Ishikura T., Lein J. PS-5, a new beta-lactam antibiotic. III. Synergistic effects and inhibitory activity against a beta-lactamase. J Antibiot (Tokyo) 1979 Apr;32(4):280–286. doi: 10.7164/antibiotics.32.280. [DOI] [PubMed] [Google Scholar]
- Okonogi K., Nozaki Y., Imada A., Kuno M. C-19393 S2 and H2, new carbapenem antibiotics. IV. Inhibitory activity against beta-lactamases. J Antibiot (Tokyo) 1981 Feb;34(2):212–217. doi: 10.7164/antibiotics.34.212. [DOI] [PubMed] [Google Scholar]
- Reading C., Cole M. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother. 1977 May;11(5):852–857. doi: 10.1128/aac.11.5.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sawada Y., Yaginuma S., Tai M., Iyobe S., Mitsuhashi S. Plasmid-mediated penicillin beta-lactamases in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1976 Jan;9(1):55–60. doi: 10.1128/aac.9.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tanaka K., Shoji J., Terui Y., Tsuji N., Kondo E., Mayama M., Kawamura Y., Hattori T., Matsumoto K., Yoshida T. Asparenomycin A, a new carbapenem antibiotic. J Antibiot (Tokyo) 1981 Jul;34(7):909–911. doi: 10.7164/antibiotics.34.909. [DOI] [PubMed] [Google Scholar]
- Toda M., Sato K., Nakazawa H., Inoue M., Mitsuhashi S. Effect of N-formimidoyl thienamycin (MK0787) on beta-lactamases and activity against beta-lactamase-producing strains. Antimicrob Agents Chemother. 1980 Nov;18(5):837–838. doi: 10.1128/aac.18.5.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yamamoto K., Yoshioka T., Kato Y., Shibamoto N., Okamura K., Shimauchi Y., Ishikura T. Structure and stereochemistry of antibiotic PS-5. J Antibiot (Tokyo) 1980 Aug;33(8):796–803. doi: 10.7164/antibiotics.33.796. [DOI] [PubMed] [Google Scholar]